$ODYS
Odysight.ai Inc. Stock $odys

$odys Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000149315223040489 Filed on November 13, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2022 Q3
Revenue	$1.946M	$110.0K	$134.0K
YoY Change	1123.9%	-17.91%	482.61%
Cost Of Revenue	$876.0K	$321.0K	$430.0K
YoY Change	148.86%	-25.35%	103.79%
Gross Profit	$1.070M	-$211.0K	-$296.0K
YoY Change	-654.4%	-28.72%	57.45%
Gross Profit Margin	54.98%	-191.82%	-220.9%
Selling, General & Admin	$1.438M	$1.307M	$981.0K
YoY Change	262.22%	33.23%	-44.95%
% of Gross Profit	134.39%
Research & Development	$1.495M	$1.354M	$1.048M
YoY Change	27.34%	29.2%	75.84%
% of Gross Profit	139.72%
Depreciation & Amortization	$45.00K	$47.00K	$57.00K
YoY Change	-50.55%	-17.54%	137.5%
% of Gross Profit	4.21%
Operating Expenses	$2.943M	$2.661M	$2.029M
YoY Change	88.17%	31.15%	-14.57%
Operating Profit	-$1.873M	-$2.872M	-$2.325M
YoY Change	6.6%	23.53%	-9.29%
Interest Expense	$332.0K	$330.0K	$73.00K
YoY Change	256.99%	352.05%	7200.0%
% of Operating Profit
Other Income/Expense, Net	$200.0K
YoY Change
Pretax Income	-$1.341M	-$2.542M	-$2.244M
YoY Change	-19.41%	13.28%	-12.41%
Income Tax
% Of Pretax Income
Net Earnings	-$1.341M	-$2.542M	-$2.244M
YoY Change	-19.41%	13.28%	-12.41%
Net Earnings / Revenue	-68.91%	-2310.91%	-1674.63%
Basic Earnings Per Share		-$0.24	-$0.32
Diluted Earnings Per Share	-$0.13	-$0.24	-$315.1K
COMMON SHARES
Basic Shares Outstanding	10.44M shares	10.44M shares	7.122M shares
Diluted Shares Outstanding		10.44M shares	7.122M shares

Balance Sheet

Concept	2023 Q4	2023 Q3	2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$17.04M	$19.51M	$15.17M
YoY Change	29.63%	28.63%	-23.12%
Cash & Equivalents	$8.945M	$15.94M	$2.586M
Short-Term Investments	$8.096M	$3.569M	$12.58M
Other Short-Term Assets	$432.0K	$573.0K	$272.0K
YoY Change	53.74%	110.66%	-49.35%
Inventory	$504.0K	$782.0K	$652.0K
Prepaid Expenses
Receivables	$1.372M		$15.00K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$19.35M	$20.86M	$16.10M
YoY Change	37.06%	29.55%	-21.16%
LONG-TERM ASSETS
Property, Plant & Equipment	$477.0K	$503.0K	$708.0K
YoY Change	-26.39%	-28.95%	-37.12%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$96.00K	$254.0K	$325.0K
YoY Change	-70.73%	-21.85%	-21.88%
Total Long-Term Assets	$3.480M	$3.694M	$2.913M
YoY Change	25.27%	26.81%	-8.28%
TOTAL ASSETS
Total Short-Term Assets	$19.35M	$20.86M	$16.10M
Total Long-Term Assets	$3.480M	$3.694M	$2.913M
Total Assets	$22.83M	$24.56M	$19.02M
YoY Change	35.12%	29.13%	-19.43%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$287.0K	$293.0K	$366.0K
YoY Change	-3.37%	-19.95%	82.09%
Accrued Expenses	$1.016M	$1.569M	$694.0K
YoY Change	30.59%	126.08%	-21.14%
Deferred Revenue	$527.0K	$950.0K	$1.429M
YoY Change	-63.04%	-33.52%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.082M	$2.864M	$2.556M
YoY Change	-18.64%	12.05%	131.1%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$28.00K	$28.00K	$2.733M
YoY Change	-98.9%	-98.98%	44.3%
Total Long-Term Liabilities	$2.940M	$3.133M	$2.733M
YoY Change	15.29%	14.64%	44.3%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.082M	$2.864M	$2.556M
Total Long-Term Liabilities	$2.940M	$3.133M	$2.733M
Total Liabilities	$5.022M	$5.997M	$5.289M
YoY Change	-1.7%	13.39%	76.3%
SHAREHOLDERS EQUITY
Retained Earnings	-$34.20M	-$32.90M	-$23.10M
YoY Change	38.11%	42.44%
Common Stock	$52.01M	$51.43M	$36.83M
YoY Change	42.32%	39.64%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$17.81M	$18.56M	$13.73M
YoY Change
Total Liabilities & Shareholders Equity	$22.83M	$24.56M	$19.02M
YoY Change	35.12%	29.13%	-19.43%

Cashflow Statement

Concept	2023 Q4	2023 Q3	2022 Q3
OPERATING ACTIVITIES
Net Income	-$1.341M	-$2.542M	-$2.244M
YoY Change	-19.41%	13.28%	-12.41%
Depreciation, Depletion And Amortization	$45.00K	$47.00K	$57.00K
YoY Change	-50.55%	-17.54%	137.5%
Cash From Operating Activities	-$2.671M	-$2.255M	-$1.709M
YoY Change	34.36%	31.95%	3.58%
INVESTING ACTIVITIES
Capital Expenditures	$19.00K	$37.00K	$45.00K
YoY Change	-38.71%	-17.78%	-114.38%
Acquisitions
YoY Change
Other Investing Activities	-$4.500M	$15.00M	-$3.000M
YoY Change	-147.37%	-600.0%
Cash From Investing Activities	-$4.519M	$14.96M	-$3.045M
YoY Change	-147.72%	-591.4%	872.84%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-26.00K	-$78.00K
YoY Change
NET CHANGE
Cash From Operating Activities	-2.671M	-$2.255M	-$1.709M
Cash From Investing Activities	-4.519M	$14.96M	-$3.045M
Cash From Financing Activities	-26.00K	-$78.00K
Net Change In Cash	-7.216M	$12.63M	-$4.754M
YoY Change	-196.46%	-365.67%	131.0%
FREE CASH FLOW
Cash From Operating Activities	-$2.671M	-$2.255M	-$1.709M
Capital Expenditures	$19.00K	$37.00K	$45.00K
Free Cash Flow	-$2.690M	-$2.292M	-$1.754M
YoY Change	33.23%	30.67%	31.19%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Central Index Key EntityCentralIndexKey	0001577445
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent		usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent		usd
CY2023Q3	us-gaap	Other Nonoperating Income OtherNonoperatingIncome		usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
CY2022Q3	SCTC	Severance Pay Asset And Liability SeverancePayAssetAndLiability		usd
CY2022Q3	SCTC	Withdrawal Short Term Deposits WithdrawalShortTermDeposits		usd
CY2023Q3	SCTC	Payments Investment To Short Term Deposits PaymentsInvestmentToShortTermDeposits		usd
	SCTC	Proceeds From Issuance Of Shares And Warrants ProceedsFromIssuanceOfSharesAndWarrants		usd
CY2022Q3	SCTC	Proceeds From Issuance Of Shares And Warrants ProceedsFromIssuanceOfSharesAndWarrants		usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
CY2022Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
	SCTC	Non Cash Change In Unpaid Issuance Expenses NonCashChangeInUnpaidIssuanceExpenses		usd
CY2022Q3	SCTC	Non Cash Change In Unpaid Issuance Expenses NonCashChangeInUnpaidIssuanceExpenses		usd
	SCTC	Contract With Customer Liability Deferred Revenue Relating To New Sales ContractWithCustomerLiabilityDeferredRevenueRelatingToNewSales		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	333-188920
	dei	Entity Registrant Name EntityRegistrantName	ODYSIGHT.AI INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-4257143
	dei	Entity Address Address Line1 EntityAddressAddressLine1	Suite 7A
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Industrial Park
	dei	Entity Address Address Line3 EntityAddressAddressLine3	P.O. Box 3030
	dei	Entity Address City Or Town EntityAddressCityOrTown	Omer
	dei	Entity Address Country EntityAddressCountry	IL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	8496500
	dei	City Area Code CityAreaCode	972
	dei	Local Phone Number LocalPhoneNumber	73 370-4690
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	10440850	shares
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	15938000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10099000	usd
CY2023Q3	us-gaap	Deposits Assets Current DepositsAssetsCurrent	3569000	usd
CY2022Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	3047000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	60000	usd
CY2023Q3	us-gaap	Inventory Gross InventoryGross	782000	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	630000	usd
CY2023Q3	us-gaap	Other Assets Current OtherAssetsCurrent	573000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	281000	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	20862000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	14117000	usd
CY2023Q3	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	1316000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	1495000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	503000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	648000	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1621000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	307000	usd
CY2023Q3	SCTC	Severance Pay Asset SeverancePayAsset	254000	usd
CY2022Q4	SCTC	Severance Pay Asset SeverancePayAsset	328000	usd
CY2023Q3	us-gaap	Assets Noncurrent AssetsNoncurrent	3694000	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	2778000	usd
CY2023Q3	us-gaap	Assets Assets	24556000	usd
CY2022Q4	us-gaap	Assets Assets	16895000	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	293000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	297000	usd
CY2023Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	950000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1426000	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	528000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	199000	usd
CY2023Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	761000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	365000	usd
CY2023Q3	SCTC	Account Payable Other Current AccountPayableOtherCurrent	280000	usd
CY2022Q4	SCTC	Account Payable Other Current AccountPayableOtherCurrent	214000	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	2864000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2559000	usd
CY2023Q3	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	1901000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	2218000	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	957000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	64000	usd
CY2023Q3	SCTC	Liability For Severance Pay LiabilityForSeverancePay	247000	usd
CY2022Q4	SCTC	Liability For Severance Pay LiabilityForSeverancePay	268000	usd
CY2023Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	28000	usd
CY2023Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	3133000	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2550000	usd
CY2023Q3	us-gaap	Liabilities Liabilities	5997000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	5109000	usd
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10440850	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10440850	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7121737	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7121737	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	10000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	7000	usd
CY2023Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	51415000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	36541000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-32866000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-24762000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	18559000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	11786000	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	24556000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	16895000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1087000	usd
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9395000	shares
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	506000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	110000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	134000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	1648000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	1279000	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	321000	usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue	430000	usd
	us-gaap	Gross Profit GrossProfit	-561000	usd
	us-gaap	Gross Profit GrossProfit	-773000	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	-211000	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	-296000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4107000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3023000	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1354000	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1048000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	877000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	617000	usd
CY2023Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	208000	usd
CY2022Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	171000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3225000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3262000	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1099000	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	810000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-8770000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-7675000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2872000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2325000	usd
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	10000	usd
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	23000	usd
CY2022Q3	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	8000	usd
	SCTC	Financing Income Expenses Net FinancingIncomeExpensesNet	656000	usd
	SCTC	Financing Income Expenses Net FinancingIncomeExpensesNet	-152000	usd
CY2023Q3	SCTC	Financing Income Expenses Net FinancingIncomeExpensesNet	330000	usd
CY2022Q3	SCTC	Financing Income Expenses Net FinancingIncomeExpensesNet	73000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8104000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-7804000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-2542000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-2244000	usd
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.86
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.86
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.10
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.10
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.24
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.24
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.32
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.32
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9395000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7122000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7122000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10439000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10439000	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7122000	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7122000	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	11786000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1056000	usd
	SCTC	Stock Issued During Period Value Of Shares And Warrants StockIssuedDuringPeriodValueOfSharesAndWarrants	13821000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8104000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	18559000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	20796000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	371000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	66000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-2542000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	18559000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	19616000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1916000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-7804000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	13728000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	15513000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	15513000	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	459000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-2244000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	13728000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	13728000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8104000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-7804000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-2542000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-2244000	usd
	us-gaap	Depreciation Depreciation	239000	usd
	us-gaap	Depreciation Depreciation	160000	usd
CY2023Q3	us-gaap	Depreciation Depreciation	47000	usd
CY2022Q3	us-gaap	Depreciation Depreciation	57000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1056000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1916000	usd
CY2023Q3	us-gaap	Share Based Compensation ShareBasedCompensation	371000	usd
CY2022Q3	us-gaap	Share Based Compensation ShareBasedCompensation	459000	usd
	SCTC	Severance Pay Asset And Liability SeverancePayAssetAndLiability	-53000	usd
	SCTC	Severance Pay Asset And Liability SeverancePayAssetAndLiability	-51000	usd
CY2023Q3	SCTC	Severance Pay Asset And Liability SeverancePayAssetAndLiability	1000	usd
	SCTC	Gain Or Loss On Exchange From Operating Lease Liability GainOrLossOnExchangeFromOperatingLeaseLiability	78000	usd
	SCTC	Gain Or Loss On Exchange From Operating Lease Liability GainOrLossOnExchangeFromOperatingLeaseLiability	52000	usd
CY2023Q3	SCTC	Gain Or Loss On Exchange From Operating Lease Liability GainOrLossOnExchangeFromOperatingLeaseLiability	56000	usd
	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	-28000	usd
CY2023Q3	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	-5000	usd
CY2022Q3	SCTC	Gain Or Loss On Exchange From Operating Lease Liability GainOrLossOnExchangeFromOperatingLeaseLiability	2000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-64000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-301000	usd
CY2023Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-11000	usd
CY2022Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	26000	usd
	SCTC	Interest Income In Respect Of Deposits InterestIncomeInRespectOfDeposits	22000	usd
	SCTC	Interest Income In Respect Of Deposits InterestIncomeInRespectOfDeposits	66000	usd
CY2023Q3	SCTC	Interest Income In Respect Of Deposits InterestIncomeInRespectOfDeposits	-167000	usd
CY2022Q3	SCTC	Interest Income In Respect Of Deposits InterestIncomeInRespectOfDeposits	43000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-60000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	7000	usd
CY2023Q3	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-158000	usd
CY2022Q3	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-84000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	152000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	485000	usd
CY2023Q3	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	58000	usd
CY2022Q3	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	43000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	292000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-171000	usd
CY2023Q3	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-95000	usd
CY2022Q3	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-138000	usd
	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-179000	usd
	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-120000	usd
CY2023Q3	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-60000	usd
CY2022Q3	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-60000	usd
	SCTC	Increase Decrease In Right Of Use Asset IncreaseDecreaseInRightOfUseAsset	211000	usd
	SCTC	Increase Decrease In Right Of Use Asset IncreaseDecreaseInRightOfUseAsset	210000	usd
CY2023Q3	SCTC	Increase Decrease In Right Of Use Asset IncreaseDecreaseInRightOfUseAsset	117000	usd
CY2022Q3	SCTC	Increase Decrease In Right Of Use Asset IncreaseDecreaseInRightOfUseAsset	78000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-4000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	263000	usd
CY2023Q3	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-481000	usd
CY2022Q3	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	57000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-793000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	1333000	usd
CY2023Q3	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-110000	usd
CY2022Q3	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-102000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-225000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-183000	usd
CY2023Q3	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-115000	usd
CY2022Q3	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-58000	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	396000	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-3000	usd
CY2023Q3	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	307000	usd
CY2022Q3	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-24000	usd
	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	6000	usd
CY2022Q3	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	-45000	usd
	SCTC	Increase Decrease In Other Account Payable IncreaseDecreaseInOtherAccountPayable	80000	usd
CY2022Q3	SCTC	Termination Of Rightofuse Assets In Exchange For Cancellation Of Operating Lease Obligations TerminationOfRightofuseAssetsInExchangeForCancellationOfOperatingLeaseObligations	-65000	usd
	SCTC	Increase Decrease In Other Account Payable IncreaseDecreaseInOtherAccountPayable	-60000	usd
CY2023Q3	SCTC	Increase Decrease In Other Account Payable IncreaseDecreaseInOtherAccountPayable	-230000	usd
CY2022Q3	SCTC	Increase Decrease In Other Account Payable IncreaseDecreaseInOtherAccountPayable	-145000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7338000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4107000	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2255000	usd
CY2022Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1709000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	94000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	87000	usd
CY2023Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	37000	usd
CY2022Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	45000	usd
	SCTC	Withdrawal Short Term Deposits WithdrawalShortTermDeposits	18000000	usd
	SCTC	Withdrawal Short Term Deposits WithdrawalShortTermDeposits	5000000	usd
CY2023Q3	SCTC	Withdrawal Short Term Deposits WithdrawalShortTermDeposits	15000000	usd
	SCTC	Payments Investment To Short Term Deposits PaymentsInvestmentToShortTermDeposits	18500000	usd
	SCTC	Payments Investment To Short Term Deposits PaymentsInvestmentToShortTermDeposits	6500000	usd
CY2022Q3	SCTC	Payments Investment To Short Term Deposits PaymentsInvestmentToShortTermDeposits	3000000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-594000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1587000	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	14963000	usd
CY2022Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3045000	usd
	SCTC	Proceeds From Issuance Of Shares And Warrants ProceedsFromIssuanceOfSharesAndWarrants	13835000	usd
CY2023Q3	SCTC	Proceeds From Issuance Of Shares And Warrants ProceedsFromIssuanceOfSharesAndWarrants	-78000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	13835000	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-78000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	5903000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-5694000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	12630000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-4754000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-64000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-301000	usd
CY2023Q3	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-11000	usd
CY2022Q3	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-26000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	10099000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8581000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3319000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7314000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	15938000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2586000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	15938000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2586000	usd
	SCTC	Non Cash Change In Unpaid Issuance Expenses NonCashChangeInUnpaidIssuanceExpenses	14000	usd
CY2023Q3	SCTC	Non Cash Change In Unpaid Issuance Expenses NonCashChangeInUnpaidIssuanceExpenses	-12000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1577000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	118000	usd
CY2023Q3	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1112000	usd
CY2022Q3	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	37000	usd
	SCTC	Termination Of Rightofuse Assets In Exchange For Cancellation Of Operating Lease Obligations TerminationOfRightofuseAssetsInExchangeForCancellationOfOperatingLeaseObligations	-52000	usd
	SCTC	Termination Of Rightofuse Assets In Exchange For Cancellation Of Operating Lease Obligations TerminationOfRightofuseAssetsInExchangeForCancellationOfOperatingLeaseObligations	-65000	usd
	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_80D_eus-gaap--NatureOfOperations_zDS7gdnwwyLd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 – <span id="xdx_823_zl80QJM8DUb9">GENERAL</span>:</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 49.6pt; text-align: justify; text-indent: -49.6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>a</b>.</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Odysight.ai.Inc (the “Company”), formerly known as ScoutCam Inc., was incorporated under the laws of the State of Nevada on March 22, 2013. Prior to the closing of the Exchange Agreement (as defined below), the Company was a non-operating “shell company”.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 5, 2023, the Company filed with the Nevada Secretary of State a Certificate of Amendment to the Registrant’s Articles of Incorporation to change its name from “ScoutCam Inc.” to “Odysight.ai Inc.”, effective June 5, 2023.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s wholly owned subsidiary, Odysight.ai Ltd (“Odysight.ai”.), formerly known as ScoutCam Ltd., was formed in the State of Israel on January 3, 2019, as a wholly-owned subsidiary of Medigus Ltd. (“Medigus”), an Israeli company traded on the Nasdaq Capital Market, and commenced operations on March 1, 2019.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In December 2019, Medigus and Odysight.ai consummated an asset transfer agreement, under which Medigus transferred and assigned certain assets and intellectual property rights related to its miniaturized imaging business to Odysight.ai.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 30, 2019, the Company and Medigus consummated a securities exchange agreement (the “Exchange Agreement”), pursuant to which Medigus delivered <span id="xdx_902_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20191230__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--MedigusMember__us-gaap--TypeOfArrangementAxis__custom--ExchangeAgreementMember_zwpU7fihE4fk" title="Ownership percentage">100</span>% of its holdings in Odysight.ai to the Company in exchange for shares of the Company’s common stock representing <span id="xdx_904_ecustom--PercentageOfExchangeForSharesIssuedAndOutstandingShareCapital_pid_dp_uPure_c20191230__20191230__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--MedigusMember__us-gaap--TypeOfArrangementAxis__custom--ExchangeAgreementMember_zjCFhZ4ZCMk8" title="Percentage of exchange for shares issued and outstanding share capital">60</span>% of the issued and outstanding share capital of the Company immediately upon the consummation of the Exchange Agreement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During 2020-2023 Medigus has decreased its holdings in the Company such that as of March 31, 2023, Medigus owned <span id="xdx_907_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20230331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--MedigusMember_zCzIYDKpLyEa">18.45</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of the Company’s outstanding common stock. On June 1, 2023, Medigus sold all its holdings in the Company to existing shareholders and to Chairman of the Board and CEO of the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company, through Odysight.ai, provides image-based platforms. Through the use of its proprietary visualization technology, Odysight.ai offers solutions across predictive maintenance and condition-based monitoring markets, in sectors such as energy, automotive and aviation. Odysight.ai’s solutions are based on small and highly resilient cameras, specialized AI analysis and supplementary technologies. Some of the Company’s products utilize micro visualization technology in medical devices for minimally invasive medical procedures.</span></p></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ODYSIGHT.AI INC. (Formerly known as ScoutCam Inc.)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 – GENERAL </b>(continued):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 60.65pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>b.</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since incorporation of Odysight.ai and through September 30, 2023, the Company accumulated a deficit of approximately $<span id="xdx_906_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pn5n6_di_c20230930_zOFIawHQtWoa" title="Accumulated deficit">32.9</span> million and its activities have been funded mainly by its shareholders. The Company’s management believes the Company’ cash and cash resources will allow the Company to fund its operating plan through at least the next 12 months from the filing date of these Interim Condensed Consolidated Financial Statements. However, the Company expects to continue to incur significant research and development and other costs related to its ongoing operations, requiring the Company to obtain additional funding in order to continue its future operations until becoming profitable.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-32900000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	0	usd
CY2023Q3	SCTC	Termination Of Rightofuse Assets In Exchange For Cancellation Of Operating Lease Obligations TerminationOfRightofuseAssetsInExchangeForCancellationOfOperatingLeaseObligations	-27000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_845_eus-gaap--UseOfEstimates_z4Y2mzw0lHed" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>c. <span id="xdx_866_zrMe2GBXomsi">Use of estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. The Company evaluates on an ongoing basis its assumptions, including those related to contingencies, deferred taxes, inventory impairment, stock-based compensation, as well as in estimates used in applying the revenue recognition policy. Actual results may differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ODYSIGHT.AI INC. (Formerly known as ScoutCam Inc.)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 2 – BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES </b>(continued):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q2	us-gaap	Sublease Income SubleaseIncome	7000	usd
CY2023Q3	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	242000	usd
CY2022Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	438000	usd
CY2023Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	277000	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	148000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	262000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	203000	usd
CY2023Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	143000	usd
CY2022Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	67000	usd
CY2023Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P0Y10M20D
CY2023Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.06	pure
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	138000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	542000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	502000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	382000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	148000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1712000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	227000	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	1485000	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P7Y
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1560040	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.64
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	684000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	3.13
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	29117	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	3.78
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2214923	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.48
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	993487	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	3.21
	us-gaap	Share Based Compensation ShareBasedCompensation	1056000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1916000	usd
CY2023Q3	us-gaap	Share Based Compensation ShareBasedCompensation	371000	usd
CY2022Q3	us-gaap	Share Based Compensation ShareBasedCompensation	459000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1087000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	506000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	110000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	134000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Useful Life PropertyPlantAndEquipmentUsefulLife	P7Y
CY2023Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	263000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	44000	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	782000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	630000	usd
CY2023Q3	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	1316000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	1495000	usd
CY2023Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	2851000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	3644000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	1495000	usd
CY2021Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	1675000	usd
	SCTC	Contract With Customer Asset Contract Costs ContractWithCustomerAssetContractCosts	-179000	usd
CY2022	SCTC	Contract With Customer Asset Contract Costs ContractWithCustomerAssetContractCosts	-180000	usd
CY2023Q3	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	1316000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	1495000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	3644000	usd
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	2420000	usd
CY2022	SCTC	Contract With Customer Liability Deferred Revenue Relating To New Sales ContractWithCustomerLiabilityDeferredRevenueRelatingToNewSales	1613000	usd
	SCTC	Contract With Customer Liability Revenue Recognized Development Services ContractWithCustomerLiabilityRevenueRecognizedDevelopmentServices	-793000	usd
CY2022	SCTC	Contract With Customer Liability Revenue Recognized Development Services ContractWithCustomerLiabilityRevenueRecognizedDevelopmentServices	-389000	usd
CY2023Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	2851000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	3644000	usd
CY2023Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	2900000	usd
	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	29000	usd
	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	87000	usd
	SCTC	Royalties Agreement Description RoyaltiesAgreementDescription	Pursuant to the agreement with the IIA relating to the program, the Company has to pay royalties of 3% to the IIA up to the amount IIA funding received and the accrued interest repayment of the grant is contingent upon the Company successfully completing its enhancement plans and generating sales from the enhancements preformed.
CY2023Q3	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	50000	usd

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
sctc-20230930_cal.xml	Edgar Link	unprocessable
0001493152-23-040489-index-headers.html	Edgar Link	pending
0001493152-23-040489-index.html	Edgar Link	pending
0001493152-23-040489.txt	Edgar Link	pending
0001493152-23-040489-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
form10-q_htm.xml	Edgar Link	completed
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
sctc-20230930.xsd	Edgar Link	pending
Show.js	Edgar Link	pending
sctc-20230930_def.xml	Edgar Link	unprocessable
sctc-20230930_lab.xml	Edgar Link	unprocessable
sctc-20230930_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ODYS
Odysight.ai Inc. Stock $odys

2023 Q4 Form 10-Q Financial Statement

#000149315223040489 Filed on November 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ODYS Odysight.ai Inc. Stock $odys

2023 Q4 Form 10-Q Financial Statement

#000149315223040489 Filed on November 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ODYS
Odysight.ai Inc. Stock $odys